Original filing (PDF)20250908183723NAL0012118819001

Oncternal Therapeutics Inc.

Name: Oncternal Therapeutics Inc. — Oncternal Therapeutics, Form 5500 (2024)
Creator: Oncternal Therapeutics Inc.
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

Oncternal Therapeutics Inc. 401(k) Plan

401(k) retirement plan · Oncternal Therapeutics Inc.'s Oncternal Therapeutics Inc. 401(k) Plan filed a Form 5500 for plan year 2024.

Active participants

Accounts w/ balance

Plan assets (EOY)

Net assets (EOY)

People on this filing

April MAY signed Oncternal Therapeutics Inc.'s 2024 Form 5500 as plan administrator.

April MAY — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

Oncternal Therapeutics Inc.'s EIN is 46-4137807.

EIN 46-4137807

Plan number 001

Plan year 2024

ACK ID 20250908183723NAL0012118819001

Official Form 5500 document

Download the official 2024 Form 5500 (PDF) for Oncternal Therapeutics Inc. from the U.S. Department of Labor's EFAST2 system.

Download the official 2024 Form 5500 (PDF)

Plan features

Oncternal Therapeutics Inc.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for ONCTERNAL THERAPEUTICS INC..

Finding similar companies…

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 50% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

n/a

Vendor & structure

100

Helping the score